Anethole trithione explained

Anethole trithione, anetholtrithione, or anetholtrithion (JAN) is a drug used in the treatment of dry mouth. It is listed in the U.S. National Cancer Institute's Dictionary of Cancer Terms as being studied in the treatment of cancer.^[1] Anethole trithione is an organosulfur compound, specifically, a dithiole-thione derivative.^[2]

Brand names

• Felviten
• Halpen
• Hepasulfol - Franco-Indian Pharmaceuticals
• Heporal
• Mucinol - Sanofi-Aventis
• Sialor - Paladin Laboratories; Pharmascience; Solvay; Zuoz Pharma
• Sonicur - Solvay
• Sulfarlem - Solvay; Aguettant; Edward Keller; Sanofi-Aventis
• Sulfarlem S - EG Labo
• Tiopropen
• Tiotrifar

See also

• Anethole

References

1. http://www.cancer.gov/dictionary?CdrID=45559 Anetholtrithione
2. Book: Christen MO . Anethole dithiolethione: Biochemical considerations . Biothiols Part B: Glutathione and Thioredoxin: Thiols in Signal Transduction and Gene Regulation . Methods in Enzymology . 252 . 316–23 . 1995 . 7476368 . 10.1016/0076-6879(95)52034-1 . 9780121821531 .